Prevalence of Latent Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A South-East London Cohort Study

被引：0
|
作者：
Paine, Gabriel Wisenfeld [1 ]
Cox, Rosie [1 ]
Evans, Rosa [1 ]
Hudson, Jake [1 ]
Baker, Lucy [1 ]
Simpson, Thomas [1 ]
机构：
[1] Lewisham & Greenwich NHS Trust, Univ Hosp Lewisham, London, England
来源：
LUNG CANCER | 2025年 / 200卷
关键词：
D O I：
10.1016/j.lungcan.2025.108243
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
133
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Inpatient and ED Use Among Melanoma and Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
    Tay, Djin L.
    Dubose, Kline
    Meeks, Huong
    Guo, Jia-Wen
    Feldner, Katie
    Alekhina, Natalya
    Sheng, Xiaoming
    Chipman, Jonathan
    Ellington, Lee
    Hashibe, Mia
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2024, 67 (05) : E826 - E827
  • [22] A qualitative research exploring the experiences of patients receiving immune checkpoint inhibitors for advanced lung cancer
    Yunxia Hou
    Yingge Hou
    Jing Li
    Lijuan Yu
    Ling Yan
    Supportive Care in Cancer, 2023, 31
  • [23] ETHNIC DIFFERENCES IN VITAMIN D LEVELS AMONG PATIENTS WITH TUBERCULOSIS IN SOUTH-EAST LONDON
    Randhawa, J. K.
    Kahr, V.
    Post, F. A.
    Barker, R. D.
    Milburn, H. J.
    THORAX, 2009, 64 : A103 - A104
  • [24] Learning about and living with toxicity: a qualitative study of patients receiving immune checkpoint inhibitors for melanoma or lung cancer and their caregivers
    Falade, Ayo S.
    Boulanger, Mary C.
    Hsu, Kelly
    Sarathy, Roshni
    Fadden, Riley
    Reynolds, Kerry L.
    Traeger, Lara
    Temel, Jennifer S.
    Greer, Joseph A.
    Petrillo, Laura A.
    SUPPORTIVE CARE IN CANCER, 2024, 32 (10)
  • [25] Drug-induced liver toxicity in a prospective cohort of cancer patients receiving immune checkpoint inhibitors
    Purde, Mette-Triin
    Niederer, Rebekka
    Diem, Stefan
    Berner, Fiamma
    Ali, Omar Hasan
    Hillmann, Dorothea
    Frueh, Martin
    Risch, Lorenz
    Semela, David
    Flatz, Lukas
    SWISS MEDICAL WEEKLY, 2019, : 4S - 4S
  • [26] Immunogenicity of Influenza Vaccination in Patients with Cancer Receiving Immune Checkpoint Inhibitors
    Keam, Bhumsuk
    Kang, Chang Kyung
    Jun, Kang Il
    Moon, Song Mi
    Suh, Koung Jin
    Lee, Dae-Won
    Ock, Chan-Young
    Kim, Miso
    Choi, Yunhee
    Lim, Yoojoo
    Lee, Kyung-Hun
    Kim, Se Hyun
    Kim, Tae Min
    Kim, Tae-Yong
    Oh, Youn
    Kim, Dong-Wan
    Im, Seock-Ah
    Lee, Jong Seok
    Kim, Eu Suk
    Kim, Hong Bin
    Kim, Nam-Joong
    Kim, Yu Jung
    Park, Wan Beom
    Oh, Myoung-don
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (02) : 422 - 425
  • [27] Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: a nationwide observational study
    Bae, Seongman
    Kim, Ye-Jee
    Kim, Min-Ju
    Kim, Jwa Hoon
    Yun, Sung-Cheol
    Jung, Jiwon
    Kim, Min Jae
    Chong, Yong Pil
    Kim, Sung-Han
    Choi, Sang-Ho
    Kim, Yang Soo
    Lee, Sang-Oh
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
  • [28] CAUSES OF HOSPITALIZATION AMONG CANCER PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS
    Choi, A.
    In, G.
    Brady, K.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 : A195 - A195
  • [29] Cardiovascular Health and Outcomes in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Oren, Ohad
    Yang, Eric H.
    Molina, Julian R.
    Bailey, Kent R.
    Blumenthal, Roger S.
    Kopecky, Stephen L.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (12): : 1920 - 1926
  • [30] Impact of comorbidity on survival in cancer patients receiving immune checkpoint inhibitors
    Yalciner, Merih
    Yazgan, Sati Coskun
    Mocan, Eda Eylemer
    Karaoglan, Beliz Bahar
    Bolek, Hatice
    Yekeduz, Emre
    Urun, Yuksel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
12345